Feverfew is primarily used to prevent migraines. While this flowering herb from the daisy family has a long folk history for treating fever, arthritis, and various inflammatory conditions, migraine prevention is the only use with meaningful clinical evidence behind it. Even there, the effect is modest: clinical trials show feverfew reduces migraine frequency by roughly one extra attack per month compared to placebo.
Migraine Prevention: What the Evidence Shows
The best-studied use of feverfew is reducing how often migraines occur, not stopping one that’s already started. In trials reviewed by the Cochrane Collaboration, people taking feverfew went from about 4.8 migraines per month down to 2.9, while those on placebo dropped from 4.8 to 3.5. That works out to about 0.6 fewer attacks per month with feverfew compared to a sugar pill. It’s a real difference, but not a dramatic one.
Notably, the trials did not find statistically significant improvements in how intense or long each migraine lasted, or in the severity of nausea and vomiting during attacks. Feverfew appears to make migraines less frequent rather than less painful when they do arrive. For people who get several migraines a month, that reduction can still be worthwhile, but it’s important to set realistic expectations.
How Feverfew Works in the Body
Feverfew’s active compound, parthenolide, appears to work by influencing serotonin, a brain chemical that plays a central role in migraine biology. Serotonin is stored in blood platelets and nerve cells, and a sudden spike in its levels can cause blood vessels to constrict, potentially triggering the aura phase of a migraine. Parthenolide inhibits the release of serotonin from both platelets and neurons, which may help keep those levels more stable.
There’s also evidence that parthenolide interacts with pain-sensing receptors in the network of nerves around the head and face, reducing pain signaling and the dilation of blood vessels that contributes to migraine pain. This dual action on both serotonin regulation and pain pathways likely explains why the herb helps some migraine sufferers even though it doesn’t work through the same pathways as conventional pain medications.
Arthritis and Inflammation
Feverfew has a reputation in folk medicine as an anti-inflammatory herb, and lab studies show parthenolide can suppress inflammatory pathways in isolated cells. This led researchers to test it for rheumatoid arthritis. A double-blind, placebo-controlled trial gave 40 women with symptomatic rheumatoid arthritis either feverfew capsules or placebo daily for six weeks. The researchers tracked pain, stiffness, grip strength, joint tenderness, inflammatory blood markers, and overall function. No meaningful differences emerged between the two groups on any measure.
Despite its anti-inflammatory activity in a test tube, feverfew has not shown clinical benefit for arthritis in human trials. If you’re looking for joint relief, this isn’t a well-supported option.
Dosage and What to Look For
The standard recommendation for migraine prevention is 125 mg daily of dried feverfew leaf, standardized to contain at least 0.2% parthenolide. Some guidelines suggest a range of 100 to 300 mg up to four times daily with 0.2% to 0.4% parthenolide content, though most trials used a single daily dose at the lower end of that range.
Standardization matters because the parthenolide content in feverfew plants varies widely depending on growing conditions, harvest time, and processing. Supplements sold in the United States, United Kingdom, and Canada are generally standardized to at least 0.2% parthenolide. If a product doesn’t specify its parthenolide content on the label, there’s no way to know whether it contains enough of the active compound to have any effect. Feverfew needs to be taken consistently over weeks to months for prevention; it is not useful as a treatment for an acute migraine that’s already underway.
Side Effects and Risks
The most common side effects are digestive: nausea, bloating, and stomach discomfort. Some people who chew raw feverfew leaves develop mouth sores and irritation, which is why capsules are the preferred form. Applying feverfew topically can cause contact dermatitis, with redness, soreness, and skin inflammation. If you’re allergic to ragweed, chamomile, or other plants in the daisy family, you may also react to feverfew.
Feverfew slows blood clotting. If you take blood-thinning medications or are scheduled for surgery, this is a meaningful concern. The NIH recommends stopping feverfew at least two weeks before any planned surgical procedure.
Post-Feverfew Syndrome
One unusual risk comes from stopping feverfew abruptly after long-term use. In a study of people who had taken raw feverfew leaves daily for three to four years, 13 out of 17 participants experienced a cluster of withdrawal symptoms during the placebo phase: joint and muscle aches, stiffness, nervousness, anxiety, and poor sleep, along with a rebound in migraine frequency. Researchers termed this “post-feverfew syndrome.”
This doesn’t mean feverfew is dangerous to take, but it does mean you shouldn’t quit cold turkey after months or years of regular use. Tapering off gradually is the sensible approach, though none of the major clinical trials actually tested a specific tapering schedule. If you’ve been using feverfew consistently and want to stop, reducing your dose over a few weeks is a reasonable strategy to minimize rebound symptoms.